A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions

Hum Mutat. 2020 Apr;41(4):850-859. doi: 10.1002/humu.23981. Epub 2020 Jan 25.

Abstract

Recently, four SCN5A mutations have been associated with Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC), a rare cardiac syndrome combining polymorphic ventricular arrhythmia with dilated cardiomyopathy (DCM). Here, we identified a novel heterozygous mutation in SCN5A (c.611C>A, pAla204Glu) in a young woman presenting with polymorphic premature ventricular contractions (PVCs) and DCM. After failure of antiarrhythmic drugs and an attempt of radiofrequency catheter ablation showing three exit-sites of PVCs, all with presystolic Purkinje potentials, a treatment by hydroquinidine was tried, leading to an immediate and spectacular disappearance of all PVCs and normalization of cardiac function. Electrophysiological studies showed that Nav 1.5-A204E mutant channels exhibited a significant leftward shift of 8 mV of the activation curve, leading to a larger hyperpolarized window current when compared to wild-type. Action potential modeling using Purkinje fiber and ventricular cell models predicted an arrhythmogenic effect predominant in Purkinje fibers for the A204E mutation. Comparison with other MEPPC-associated Nav 1.5 mutations revealed a common electrophysiological pattern of abnormal voltage-dependence of activation leading to a larger hyperpolarized window current as a shared biophysical mechanism of this syndrome. These features of the mutant sodium channels are likely to be responsible for the hyperexcitability of the fascicular-Purkinje system observed in patients with MEPPC.

Keywords: Purkinje; SCN5A; dilated cardiomyopathy; electrophysiology; gain-of-function mutation; polymorphic premature ventricular complexes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alleles
  • Base Sequence
  • DNA Mutational Analysis
  • Electrocardiography
  • Female
  • Gain of Function Mutation
  • Genetic Association Studies* / methods
  • Genetic Predisposition to Disease*
  • Genetic Testing
  • Genotype
  • Humans
  • Magnetic Resonance Imaging
  • NAV1.5 Voltage-Gated Sodium Channel
  • Phenotype
  • Purkinje Fibers / metabolism*
  • Purkinje Fibers / physiopathology*
  • Ventricular Premature Complexes / diagnosis*
  • Ventricular Premature Complexes / drug therapy
  • Ventricular Premature Complexes / etiology*

Substances

  • NAV1.5 Voltage-Gated Sodium Channel
  • SCN5A protein, human